Pharmaceuticals
405 US-listed companies in this industry.
Companies
405 listed
| Company | Revenue | Net income | Margin | ROE | Revenue 5y | Years |
|---|---|---|---|---|---|---|
| JNJJOHNSON & JOHNSON | $94.19 B | $26.80 B | 28.5% | 35.0% | +2.7% | 19 |
| LLYELI LILLY & Co | $65.18 B | $20.64 B | 31.7% | 101.2% | +21.6% | 19 |
| MRKMerck & Co., Inc. | $65.01 B | $18.25 B | 28.1% | 36.9% | +9.4% | 19 |
| PFEPFIZER INC | $62.58 B | $7.77 B | 12.5% | 8.9% | +8.5% | 19 |
| ABBVAbbVie Inc. | $61.16 B | $4.23 B | 6.9% | · | +6.0% | 15 |
| AZNASTRAZENECA PLC | $58.74 B | $10.22 B | 17.4% | 22.9% | +17.2% | 11 |
| NVSNOVARTIS AG | $54.53 B | $13.98 B | 25.6% | 31.0% | +2.3% | 10 |
| BMYBRISTOL MYERS SQUIBB CO | $48.19 B | $7.05 B | 14.6% | 40.5% | +2.5% | 19 |
| ABTABBOTT LABORATORIES | $44.33 B | $6.52 B | 14.7% | 13.1% | +5.1% | 19 |
| TEVATEVA PHARMACEUTICAL INDUSTRIES LTD | $17.26 B | $1.41 B | 8.2% | 21.2% | +0.7% | 17 |
| REGNREGENERON PHARMACEUTICALS, INC. | $14.34 B | $4.50 B | 31.4% | 14.9% | +11.0% | 18 |
| VTRSViatris Inc | $14.30 B | -$3.51 B | -24.6% | · | +3.7% | 8 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | $12.00 B | $3.95 B | 32.9% | 22.5% | +14.1% | 18 |
| BHCBausch Health Companies Inc. | $10.27 B | $157.0 M | 1.2% | · | +5.0% | 18 |
| ZTSZoetis Inc. | $9.47 B | $2.67 B | 28.2% | 66.0% | +7.2% | 15 |
| OGNOrganon & Co. | $6.22 B | $187.0 M | 3.0% | 30.6% | -1.0% | 7 |
| ONCBeOne Medicines Ltd. | $5.34 B | $286.9 M | 5.4% | 7.5% | +76.8% | 12 |
| ELANElanco Animal Health Inc | $4.71 B | -$232.0 M | -4.9% | -3.7% | +7.6% | 10 |
| JAZZJazz Pharmaceuticals plc | $4.27 B | -$356.1 M | -8.3% | -8.5% | +12.5% | 17 |
| PRGOPERRIGO Co plc | $4.25 B | -$1.43 B | -33.5% | -39.3% | +0.8% | 14 |
| GMABGENMAB A/S | $3.72 B | $963.0 M | 25.9% | 4.5% | · | 6 |
| ALNYALNYLAM PHARMACEUTICALS, INC. | $3.71 B | $313.7 M | 8.4% | 73.3% | +49.8% | 13 |
| BMRNBIOMARIN PHARMACEUTICAL INC | $3.22 B | $348.9 M | 10.8% | 5.9% | +11.6% | 18 |
| UTHRUNITED THERAPEUTICS Corp | $3.18 B | $1.33 B | 41.9% | 19.7% | +16.5% | 18 |
| AMRXAmneal Pharmaceuticals, Inc. | $3.02 B | $72.1 M | 4.2% | · | +8.7% | 10 |
| RPRXRoyalty Pharma plc | $2.38 B | $770.9 M | 55.7% | 7.7% | +2.3% | 8 |
| SRPTSarepta Therapeutics, Inc. | $2.20 B | -$713.4 M | -32.5% | -53.5% | +32.4% | 12 |
| PTCTPTC THERAPEUTICS, INC. | $1.73 B | $682.6 M | 39.4% | · | +35.4% | 15 |
| PAHCPHIBRO ANIMAL HEALTH CORP | $1.52 B | $99.7 M | 6.6% | 29.7% | +12.7% | 15 |
| ALKSAlkermes plc. | $1.48 B | $241.7 M | 16.4% | 14.7% | +7.3% | 17 |
| INDVIndivior Pharmaceuticals, Inc. | $1.24 B | $210.0 M | 16.9% | · | · | 4 |
| PBHPrestige Consumer Healthcare Inc. | $1.09 B | $190.3 M | 17.5% | 10.2% | +2.9% | 17 |
| ACADACADIA PHARMACEUTICALS INC | $1.07 B | $391.0 M | 36.5% | 39.9% | +19.4% | 17 |
| LEGNLegend Biotech Corp | $1.03 B | -$296.8 M | -28.8% | -29.1% | +68.8% | 8 |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | $958.4 M | -$288.3 M | -30.1% | -42.5% | · | 10 |
| IONSIONIS PHARMACEUTICALS INC | $943.7 M | -$381.4 M | -40.4% | -70.8% | +5.3% | 18 |
| ANIPANI PHARMACEUTICALS INC | $883.4 M | $78.3 M | 8.9% | 16.6% | +33.5% | 17 |
| HRMYHarmony Biosciences Holdings, Inc. | $868.5 M | $158.7 M | 18.3% | 20.8% | +40.3% | 7 |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | $829.4 M | -$1.6 M | · | -0.5% | +56.6% | 15 |
| TLXTelix Pharmaceuticals Ltd | $803.8 M | -$7.1 M | -0.9% | -1.9% | · | 4 |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | $780.6 M | $62.9 M | 8.1% | 23.7% | +20.3% | 10 |
| CORTCORCEPT THERAPEUTICS INC | $761.4 M | $99.7 M | 13.1% | 15.0% | +16.6% | 15 |
| PCRXPacira BioSciences, Inc. | $726.4 M | $7.0 M | 1.0% | 1.0% | +11.1% | 17 |
| AMPHAmphastar Pharmaceuticals, Inc. | $719.9 M | $98.1 M | 13.6% | 12.9% | +15.5% | 14 |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | $719.0 M | -$38.5 M | -5.4% | -3.7% | +6.7% | 16 |
| KNSAKiniksa Pharmaceuticals International, | $677.6 M | $59.0 M | 8.7% | 11.7% | · | 5 |
| RAREUltragenyx Pharmaceutical Inc. | $673.0 M | -$575.0 M | -85.4% | · | +19.9% | 10 |
| AXSMAxsome Therapeutics, Inc. | $638.5 M | -$183.2 M | -28.7% | -252.1% | · | 4 |
| TGTXTG THERAPEUTICS, INC. | $616.3 M | $447.2 M | 72.6% | 102.8% | +426.7% | 10 |
| INSMINSMED Inc | $606.4 M | -$1.28 B | -210.5% | -249.3% | +29.8% | 16 |
| HCMHUTCHMED (China) Ltd | $548.5 M | $456.9 M | 83.4% | 45.7% | +19.2% | 12 |
| MIRMMirum Pharmaceuticals, Inc. | $521.3 M | -$23.4 M | -4.5% | -8.6% | · | 6 |
| BBIOBridgeBio Pharma, Inc. | $502.1 M | -$732.9 M | -146.0% | · | +127.4% | 7 |
| TVTXTravere Therapeutics, Inc. | $490.7 M | -$25.5 M | -5.2% | -29.4% | +19.9% | 15 |
| ZLABZai Lab Ltd | $460.2 M | -$175.5 M | -38.1% | -22.6% | +56.5% | 8 |
| INVAInnoviva, Inc. | $411.3 M | $271.2 M | 65.9% | 29.1% | +4.1% | 17 |
| ARDXARDELYX, INC. | $407.3 M | -$61.6 M | -15.1% | -36.2% | +121.9% | 13 |
| ARQTArcutis Biotherapeutics, Inc. | $376.1 M | -$16.1 M | -4.3% | -9.3% | · | 6 |
| MNKDMANNKIND CORP | $349.0 M | $5.9 M | 1.7% | · | +39.9% | 16 |
| XERSXeris Biopharma Holdings, Inc. | $291.8 M | $554,000 | 0.2% | · | +70.2% | 6 |
| AUPHAurinia Pharmaceuticals Inc. | $283.1 M | $287.2 M | 101.5% | 59.9% | +41.4% | 8 |
| HROWHARROW, INC. | $272.3 M | -$5.1 M | -1.9% | -8.4% | +41.0% | 13 |
| LGNDLIGAND PHARMACEUTICALS INC | $268.1 M | $124.5 M | 46.4% | 13.5% | +10.4% | 17 |
| SDGRSchrodinger, Inc. | $255.9 M | -$103.3 M | -40.4% | -26.3% | +18.8% | 7 |
| RCUSArcus Biosciences, Inc. | $247.0 M | -$353.0 M | -142.9% | -63.3% | +25.9% | 9 |
| AKBAAkebia Therapeutics, Inc. | $236.2 M | -$5.3 M | -2.3% | · | -4.3% | 12 |
| IDYAIDEAYA Biosciences, Inc. | $218.7 M | -$113.7 M | -52.0% | -10.9% | +62.1% | 7 |
| RYTMRHYTHM PHARMACEUTICALS, INC. | $189.8 M | -$196.5 M | -103.6% | -244.5% | · | 10 |
| SNDXSyndax Pharmaceuticals Inc | $172.4 M | -$285.4 M | -165.6% | -161.8% | · | 11 |
| CYTKCYTOKINETICS INC | $88.0 M | -$785.0 M | -891.6% | · | +9.5% | 17 |
| NRIXNurix Therapeutics, Inc. | $84.0 M | -$264.5 M | -314.9% | -49.6% | +36.3% | 7 |
| ABCLAbCellera Biologics Inc. | $75.1 M | -$146.4 M | -194.9% | -14.5% | -20.3% | 7 |
| VRDNViridian Therapeutics, Inc.\DE | $70.8 M | -$342.6 M | · | -49.2% | +132.2% | 13 |
| AGIOAGIOS PHARMACEUTICALS, INC. | $54.0 M | -$412.8 M | -764.0% | -30.2% | · | 15 |
| OCULOCULAR THERAPEUTIX, INC | $52.0 M | -$265.9 M | -511.9% | -54.9% | +24.4% | 13 |
| PTGXProtagonist Therapeutics, Inc | $46.0 M | -$130.1 M | -282.8% | -20.2% | +10.0% | 9 |
| WVEWave Life Sciences, Inc. | $42.7 M | -$204.4 M | -478.3% | -56.2% | +16.3% | 11 |
| NAMSNewAmsterdam Pharma Co N.V. | $22.5 M | -$203.8 M | -905.7% | -28.3% | · | 4 |
| QUREuniQure N.V. | $16.1 M | -$199.0 M | -1236.0% | · | -15.6% | 12 |
| JANXJanux Therapeutics, Inc. | $10.0 M | -$113.6 M | -1136.2% | -11.5% | · | 6 |
| ROIVRoivant Sciences Ltd. | $8.3 M | -$299.8 M | · | -6.5% | · | 6 |
| CRNXCrinetics Pharmaceuticals, Inc. | $7.7 M | -$465.3 M | · | -40.2% | +155.3% | 10 |
| XENEXenon Pharmaceuticals Inc. | $7.5 M | -$345.9 M | · | -51.8% | · | 13 |
| PRAXPraxis Precision Medicines, Inc. | $0 | -$303.3 M | · | -45.8% | · | 4 |
| SYRESpyre Therapeutics, Inc. | $0 | -$155.2 M | · | -25.2% | · | 10 |
| VKTXViking Therapeutics, Inc. | $0 | -$359.6 M | · | -47.3% | · | 12 |
| TAKTAKEDA PHARMACEUTICAL CO LTD | JPY 4.58 T | JPY 107.93 B | 2.4% | 1.5% | +6.8% | 9 |
| RDYDR REDDYS LABORATORIES LTD | INR 325.54 B | INR 56.54 B | 17.6% | 18.4% | +13.3% | 10 |
| NVONOVO NORDISK A S | DKK 309.06 B | DKK 102.43 B | 33.1% | 60.7% | +19.5% | 7 |
| SNYSanofi | EUR 43.63 B | EUR 7.81 B | 18.0% | 10.5% | +3.9% | 11 |
| GSKGSK plc | GBP 32.67 B | GBP 5.72 B | 19.3% | 38.0% | +6.0% | 11 |
| GRFSGrifols SA | EUR 7.21 B | EUR 156.9 M | 3.0% | 2.8% | +7.2% | 10 |
| LKFTLakefront Biotherapeutics NV | EUR 1.11 B | EUR 320.9 M | 28.8% | 10.5% | +18.4% | 11 |
| EVOEvotec SE | EUR 797.0 M | -EUR 196.1 M | -24.6% | -18.9% | +12.3% | 6 |
| ASNDAscendis Pharma A/S | EUR 720.1 M | -EUR 228.0 M | -31.7% | · | +153.0% | 11 |
| COGTCogent Biosciences, Inc. | · | -$328.9 M | · | -73.7% | · | 4 |
| GERNGERON CORP | · | -$83.5 M | · | -33.0% | · | 15 |
| MLTXMoonLake Immunotherapeutics | · | -$227.3 M | · | -60.5% | · | 0 |
| PHVSPharvaris N.V. | · | -EUR 175.7 M | · | -65.2% | · | 0 |
| SMMTSummit Therapeutics Inc. | · | -$1.08 B | · | -206.1% | · | 6 |
| EBSEmergent BioSolutions Inc. | $742.9 M | $52.6 M | 7.1% | 10.5% | -14.0% | 17 |
| OPKOPKO HEALTH, INC. | $606.9 M | -$225.7 M | -37.2% | -17.1% | -15.8% | 17 |
| ORGOOrganogenesis Holdings Inc. | $564.2 M | $37.0 M | 6.6% | 13.2% | +10.8% | 10 |
| NATRNATURES SUNSHINE PRODUCTS INC | $480.1 M | $19.5 M | 4.3% | 12.1% | +4.5% | 17 |
| SVASINOVAC BIOTECH LTD | $386.0 M | -$198.8 M | -51.5% | · | -5.4% | 17 |
| PHARPharming Group N.V. | $376.1 M | $2.9 M | 0.7% | 1.1% | +12.1% | 8 |
| EOLSEvolus, Inc. | $297.2 M | -$51.6 M | -17.4% | · | +39.4% | 8 |
| IRWDIRONWOOD PHARMACEUTICALS INC | $296.2 M | $24.0 M | 8.1% | · | -5.3% | 17 |
| RIGLRIGEL PHARMACEUTICALS INC | $294.3 M | $367.0 M | 124.7% | 185.9% | +22.1% | 10 |
| ARVNARVINAS, INC. | $262.6 M | -$80.8 M | -30.8% | -16.2% | +58.9% | 9 |
| PBYIPUMA BIOTECHNOLOGY, INC. | $228.4 M | $31.1 M | 13.6% | 28.0% | +0.3% | 9 |
| VNDAVanda Pharmaceuticals Inc. | $216.1 M | -$220.5 M | -102.0% | -50.9% | -2.7% | 17 |
| AMRNAMARIN CORP PLC\UK | $213.6 M | -$38.8 M | -18.2% | -8.2% | -19.0% | 13 |
| MRVIMARAVAI LIFESCIENCES HOLDINGS, INC. | $185.7 M | -$130.8 M | -124.2% | -48.6% | -8.1% | 7 |
| LFVNLifevantage Corp | $182.6 M | $5.1 M | · | 14.9% | -3.7% | 16 |
| KMDAKAMADA LTD | $180.5 M | $20.2 M | 11.2% | 7.6% | +6.3% | 11 |
| CYRXCryoport, Inc. | $176.2 M | $78.3 M | 44.4% | 17.3% | +17.5% | 16 |
| HRTXHERON THERAPEUTICS, INC. | $154.9 M | -$20.2 M | -13.0% | · | +11.8% | 10 |
| LFCRLIFECORE BIOMEDICAL, INC. \DE\ | $128.9 M | -$38.7 M | -30.0% | -612.1% | · | 16 |
| XNCRXencor Inc | $125.6 M | -$91.9 M | -73.4% | -14.0% | +0.5% | 10 |
| GYREGYRE THERAPEUTICS, INC. | $116.6 M | $9.9 M | 8.5% | 11.7% | +41.0% | 14 |
| SIGASIGA TECHNOLOGIES INC | $94.6 M | $23.3 M | 24.6% | 11.2% | -5.4% | 10 |
| LABSTANDARD BIOTOOLS INC. | $85.3 M | -$74.9 M | -87.8% | -16.7% | -9.2% | 17 |
| ARCTArcturus Therapeutics Holdings Inc. | $82.0 M | -$65.8 M | -80.2% | -28.9% | +53.8% | 8 |
| CTMXCytomX Therapeutics, Inc. | $76.2 M | -$17.4 M | -22.8% | · | +2.2% | 13 |
| ADAGAdagene Inc. | $7.7 M | -$17.6 M | · | -41.0% | +61.4% | 8 |
| PTCHFPureTech Health plc | $4.8 M | $53.5 M | 575.4% | 12.2% | -13.2% | 7 |
| NBTXNanobiotix S.A. | EUR 32.6 M | -EUR 24.0 M | -73.5% | · | +67.0% | 8 |
| PRQRProQR Therapeutics N.V. | EUR 15.9 M | -EUR 42.2 M | -265.2% | -61.2% | · | 5 |
| IMMPIMMUTEP Ltd | AUD 10.3 M | -AUD 61.4 M | -594.6% | -36.9% | -8.9% | 10 |
| IVAInventiva S.A. | EUR 9.2 M | -EUR 184.2 M | · | · | +5.6% | 7 |
| ACIUAC Immune SA | CHF 3.6 M | -CHF 70.4 M | · | -89.7% | · | 11 |
| PRTAPROTHENA CORP PUBLIC LTD CO | · | -$244.1 M | · | -63.6% | · | 10 |
| UPCUniverse Pharmaceuticals INC | $17.86 B | -$3.67 B | -20.6% | -7.2% | +257.2% | 7 |
| CRMDCorMedix Inc. | $311.7 M | $163.1 M | 52.3% | 66.6% | · | 13 |
| KROSKeros Therapeutics, Inc. | $244.1 M | $87.0 M | 35.7% | 19.9% | · | 7 |
| ANABANAPTYSBIO, INC | $234.6 M | -$13.2 M | -5.6% | -24.5% | +25.6% | 11 |
| STOKStoke Therapeutics, Inc. | $184.4 M | -$6.9 M | -3.7% | -2.4% | · | 4 |
| PHATPhathom Pharmaceuticals, Inc. | $175.1 M | -$221.2 M | -126.3% | · | · | 4 |
| LQDALiquidia Corp | $158.3 M | -$68.9 M | -43.5% | -111.1% | +192.5% | 7 |
| MGNXMACROGENICS INC | $149.5 M | -$74.6 M | -49.9% | -86.9% | +7.3% | 15 |
| ELTPELITE PHARMACEUTICALS INC | $148.9 M | $44.9 M | 30.1% | 58.9% | +42.4% | 16 |
| KPTIKaryopharm Therapeutics Inc. | $146.1 M | -$196.0 M | -134.2% | · | +6.2% | 15 |
| URGNUroGen Pharma Ltd. | $109.8 M | -$153.5 M | -139.8% | · | +56.2% | 10 |
| TBPHTheravance Biopharma, Inc. | $107.5 M | $105.9 M | 98.5% | 44.8% | +8.4% | 14 |
| ZVRAZEVRA THERAPEUTICS, INC. | $106.5 M | $83.2 M | 78.2% | 85.7% | +51.6% | 11 |
| ZYMEZymeworks Inc. | $106.0 M | -$81.1 M | -76.6% | -26.7% | +22.2% | 6 |
| SPRYARS Pharmaceuticals, Inc. | $84.3 M | -$171.3 M | -203.3% | -92.3% | · | 5 |
| ADCTADC Therapeutics SA | $81.4 M | -$142.6 M | -175.3% | · | · | 4 |
| ETONEton Pharmaceuticals, Inc. | $80.0 M | -$4.6 M | -5.8% | -18.2% | +359.6% | 7 |
| BCYCBICYCLE THERAPEUTICS PLC | $72.6 M | -$219.0 M | -301.7% | -31.2% | +47.5% | 9 |
| ASMBASSEMBLY BIOSCIENCES, INC. | $72.3 M | -$6.1 M | -8.5% | -5.1% | · | 10 |
| RMTIROCKWELL MEDICAL, INC. | $69.3 M | -$5.3 M | -7.7% | -15.3% | +2.2% | 17 |
| KURAKura Oncology, Inc. | $67.5 M | -$278.7 M | -412.9% | -94.8% | · | 3 |
| SPROSpero Therapeutics, Inc. | $66.8 M | $8.6 M | 12.8% | 16.3% | +48.2% | 10 |
| ENTAENANTA PHARMACEUTICALS INC | $65.3 M | -$81.9 M | -125.4% | -84.6% | -11.8% | 15 |
| FBIOFortress Biotech, Inc. | $63.3 M | $6.8 M | -52.0% | 18.8% | +6.8% | 13 |
| NUVBNuvation Bio Inc. | $62.9 M | -$204.6 M | -325.3% | -53.2% | · | 3 |
| TNGXTango Therapeutics, Inc. | $62.4 M | -$101.6 M | -162.9% | -37.2% | +52.1% | 6 |
| DERMJourney Medical Corp | $61.9 M | -$11.4 M | -18.5% | -44.0% | +6.8% | 6 |
| AYTUAYTU BIOPHARMA, INC | $57.6 M | -$14.3 M | -24.8% | -52.6% | -2.6% | 14 |
| NKTRNEKTAR THERAPEUTICS | $55.2 M | -$164.1 M | -297.1% | -217.9% | -18.4% | 17 |
| QTTBQ32 Bio Inc. | $53.7 M | $29.8 M | 55.5% | 125.1% | · | 8 |
| LXRXLEXICON PHARMACEUTICALS, INC. | $49.8 M | -$50.3 M | -101.1% | -39.7% | +15.7% | 17 |
| GOSSGossamer Bio, Inc. | $48.5 M | -$170.4 M | -351.5% | · | · | 4 |
| AQSTAquestive Therapeutics, Inc. | $44.5 M | -$83.8 M | -188.1% | · | -0.6% | 9 |
| CPIXCUMBERLAND PHARMACEUTICALS INC | $44.5 M | -$2.8 M | -6.4% | -11.9% | +3.5% | 17 |
| INBPINTEGRATED BIOPHARMA INC | $43.9 M | -$2.8 M | -6.5% | -15.0% | -7.1% | 16 |
| BGMBGM Group Ltd. | $37.9 M | -$19.9 M | -53.3% | -9.2% | -5.4% | 8 |
| LIFDLFTD PARTNERS INC. | $36.9 M | -$24.9 M | -67.3% | -99.2% | +47.2% | 10 |
| SBFMSunshine Biopharma Inc. | $36.3 M | -$6.0 M | -16.5% | -25.7% | +247.7% | 16 |
| ETSTEarth Science Tech, Inc. | $35.7 M | $3.6 M | · | 66.9% | +202.5% | 13 |
| VRCAVerrica Pharmaceuticals Inc. | $35.6 M | -$17.9 M | -50.3% | · | · | 5 |
| ZOMDFZomedica Corp. | $32.0 M | -$81.9 M | -255.6% | -52.6% | · | 6 |
| VSTMVerastem, Inc. | $30.9 M | -$209.5 M | -677.6% | · | · | 7 |
| FHTXFoghorn Therapeutics Inc. | $30.9 M | -$74.3 M | -240.3% | · | +135.1% | 6 |
| PREPrenetics Global Ltd | $30.6 M | -$46.3 M | -162.7% | -24.6% | · | 5 |
| CUECue Biopharma, Inc. | $27.5 M | -$26.6 M | -96.9% | -121.1% | +54.2% | 8 |
| CELUCelularity Inc | $26.6 M | -$91.7 M | -345.4% | · | +13.2% | 6 |
| CASIFCASI Pharmaceuticals, Inc. | $20.7 M | -$48.1 M | -232.0% | · | +6.5% | 6 |
| SCYXSCYNEXIS INC | $20.6 M | -$8.6 M | -41.8% | -16.5% | · | 13 |
| EVFMEvofem Biosciences, Inc. | $20.2 M | $391,000 | 1.9% | · | +114.4% | 7 |
| SLGLSol-Gel Technologies Ltd. | $19.4 M | -$6.1 M | -31.6% | -23.7% | +17.2% | 9 |
| IRDOpus Genetics, Inc. | $14.2 M | -$49.6 M | -349.3% | -449.4% | · | 12 |
| ABUSArbutus Biopharma Corp | $14.1 M | -$33.5 M | -237.9% | -38.5% | +15.3% | 17 |
| CVSICV Sciences, Inc. | $13.8 M | -$958,000 | -6.9% | -58.7% | -10.8% | 14 |
| PTNPALATIN TECHNOLOGIES INC | $13.2 M | -$8.4 M | · | · | · | 16 |
| TNXPTonix Pharmaceuticals Holding Corp. | $13.1 M | -$124.0 M | -946.2% | -64.5% | · | 3 |
| EMMAEmmaus Life Sciences, Inc. | $12.5 M | -$7.5 M | -60.2% | · | -11.7% | 15 |
| JAGXJaguar Health, Inc. | $11.5 M | -$53.6 M | -469.1% | · | +4.2% | 12 |
| CBIOCRESCENT BIOPHARMA, INC. | $10.8 M | -$153.9 M | -1419.6% | · | · | 10 |
| PGENPRECIGEN, INC. | $9.7 M | -$250.6 M | · | -843.6% | -21.3% | 15 |
| ISCOInternational Stem Cell CORP | $9.1 M | -$418,000 | -4.6% | · | +5.0% | 16 |
| RDHLRedHill Biopharma Ltd. | $8.0 M | -$8.3 M | -102.8% | · | +5.0% | 10 |
| ACRSAclaris Therapeutics, Inc. | $7.8 M | -$64.9 M | -829.6% | -50.2% | +3.8% | 9 |
| OVIDOvid Therapeutics Inc. | $7.3 M | -$17.4 M | -240.1% | -17.5% | -10.5% | 6 |
| WHWKWhitehawk Therapeutics, Inc. | $7.1 M | -$20.6 M | -288.3% | -21.8% | -12.6% | 8 |
| KYNBKYNTRA BIO, INC. | $6.4 M | $183.5 M | · | · | · | 13 |
| KRROKorro Bio, Inc. | $6.4 M | -$117.3 M | · | -110.7% | · | 7 |
| ABEOABEONA THERAPEUTICS INC. | $5.8 M | $71.2 M | 1223.1% | 70.0% | · | 14 |
| ENSCEnsysce Biosciences, Inc. | $5.1 M | -$10.2 M | -200.8% | · | +5.2% | 6 |
| PCYNPROCYON CORP | $5.0 M | -$341,140 | -6.8% | -13.9% | +3.5% | 14 |
| PRPHProPhase Labs, Inc. | $4.3 M | -$14.7 M | -339.3% | -271.5% | -21.4% | 17 |
| CPHICHINA PHARMA HOLDINGS, INC. | $4.1 M | -$3.2 M | -76.9% | -20.9% | -17.5% | 16 |
| CRVOCervoMed Inc. | $4.0 M | -$27.0 M | -673.1% | -93.9% | · | 8 |
| RADXRadiopharm Theranostics Ltd | $3.6 M | -$38.3 M | -1055.3% | -109.2% | · | 3 |
| MRKRMarker Therapeutics, Inc. | $3.5 M | -$12.2 M | -343.0% | -68.8% | +48.0% | 9 |
| TXMDTherapeuticsMD, Inc. | $3.0 M | -$569,000 | -18.8% | -2.1% | · | 15 |
| XBIOXenetic Biosciences, Inc. | $3.0 M | -$2.7 M | -90.1% | -40.0% | +46.8% | 14 |
| RNACCartesian Therapeutics, Inc. | $2.8 M | -$130.3 M | · | · | -30.0% | 12 |
| TRAWTraws Pharma, Inc. | $2.8 M | $9.2 M | 328.7% | · | +64.6% | 15 |
| GOVXGeoVax Labs, Inc. | $2.5 M | -$21.5 M | -862.3% | -483.8% | · | 10 |
| KRSAKorsana Biosciences, Inc. | $2.1 M | -$3.5 M | -170.1% | -39.3% | · | 7 |
| DNTHDianthus Therapeutics, Inc. | $2.0 M | -$162.3 M | · | -38.4% | · | 7 |
| ORMPORAMED PHARMACEUTICALS INC. | $2.0 M | $64.0 M | · | 37.0% | · | 9 |
| LPCNLipocine Inc. | $2.0 M | -$9.6 M | -487.1% | -54.3% | · | 12 |
| BIOEBio Essence Corp | $1.9 M | $896,197 | · | · | +14.6% | 6 |
| RANIRani Therapeutics Holdings, Inc. | $1.6 M | -$29.7 M | · | -169.6% | · | 6 |
| NRXPNRX Pharmaceuticals, Inc. | $1.4 M | -$28.6 M | · | · | · | 3 |
| ATXIAVENUE THERAPEUTICS, INC. | $1.4 M | -$2.9 M | -209.9% | -125.7% | · | 2 |
| NWBONORTHWEST BIOTHERAPEUTICS INC | $1.4 M | -$60.2 M | · | · | +1.3% | 16 |
| CPMDCANNAPHARMARX, INC. | $1.4 M | -$11.1 M | -817.2% | · | · | 13 |
| SPRCSciSparc Ltd. | $1.3 M | -$6.3 M | -572.1% | -79.7% | · | 3 |
| IGCIGC Pharma, Inc. | $1.3 M | -$7.1 M | -560.3% | -104.3% | -20.8% | 15 |
| VTGNVistagen Therapeutics, Inc. | $1.3 M | -$69.7 M | · | -131.6% | +3.1% | 13 |
| BLRXBioLineRx Ltd. | $1.2 M | -$2.0 M | -171.7% | · | · | 5 |
| SXTCChina SXT Pharmaceuticals, Inc. | $1.1 M | -$6.2 M | -545.2% | -27.5% | -24.9% | 10 |
| DAREDare Bioscience, Inc. | $1.0 M | -$13.4 M | · | · | · | 9 |
| STTKShattuck Labs, Inc. | $1.0 M | -$48.8 M | · | -60.3% | -36.8% | 7 |
| RFLRafael Holdings, Inc. | $917,000 | -$30.5 M | · | -34.6% | · | 10 |
| MCRBSeres Therapeutics, Inc. | $789,000 | $5.7 M | 721.9% | 19.6% | · | 11 |
| LEXXLexaria Bioscience Corp. | $705,923 | -$11.9 M | · | -215.9% | +17.5% | 14 |
| PMHSPolomar Health Services, Inc. | $648,231 | -$10.7 M | · | · | · | 4 |
| BTAIQBioXcel Therapeutics, Inc. | $642,000 | -$69.9 M | · | · | · | 4 |
| VCNXVACCINEX, INC. | $601,000 | -$18.6 M | · | · | +2.8% | 8 |
| YARWYarrow Bioscience, Inc. | $570,000 | -$26.5 M | · | -66.3% | -51.4% | 10 |
| SLNSilence Therapeutics plc | $559,000 | -$88.6 M | · | -90.3% | · | 4 |
| SCNXScienture Holdings, Inc. | $431,609 | -$41.5 M | · | -55.6% | · | 13 |
| MNOVMEDICINOVA INC | $409,657 | -$12.0 M | · | -25.5% | · | 5 |
| CANFCan-Fite BioPharma Ltd. | $405,000 | -$9.8 M | · | -178.2% | -11.9% | 8 |
| AAGHAmerica Great Health | $391,743 | -$719,119 | -184.1% | · | +134.9% | 13 |
| PVCTPROVECTUS BIOPHARMACEUTICALS, INC. | $336,108 | -$5.4 M | · | · | · | 9 |
| ABVCABVC BIOPHARMA, INC. | $296,000 | -$7.9 M | · | -128.2% | -9.3% | 14 |
| RGBPRegen BioPharma Inc | $236,561 | -$1.3 M | -538.8% | · | +16.5% | 12 |
| CLNNClene Inc. | $200,000 | -$26.2 M | · | · | -0.6% | 6 |
| LSTALISATA THERAPEUTICS, INC. | $170,000 | -$16.6 M | · | -74.7% | · | 11 |
| SERSerina Therapeutics, Inc. | $130,000 | -$19.2 M | · | · | -18.5% | 9 |
| IBIOiBio, Inc. | $100,000 | -$33.0 M | · | -65.7% | · | 16 |
| ATNMActinium Pharmaceuticals, Inc. | $90,000 | -$33.9 M | · | -167.0% | · | 6 |
| SILOSilo Pharma, Inc. | $72,102 | -$4.2 M | · | -74.6% | · | 6 |
| INOINOVIO PHARMACEUTICALS, INC. | $65,343 | -$84.9 M | · | -183.5% | -61.2% | 17 |
| AVTXAvalo Therapeutics, Inc. | $59,000 | -$78.3 M | · | -72.4% | -61.2% | 11 |
| LNAILunai Bioworks Inc. | $51,992 | -$3.6 M | · | · | · | 5 |
| ALTAltimmune, Inc. | $41,000 | -$88.1 M | · | -50.6% | -65.3% | 12 |
| AXIMAXIM BIOTECHNOLOGIES, INC. | $39,518 | -$8.1 M | · | · | · | 13 |
| LYELLyell Immunopharma, Inc. | $36,000 | -$274.4 M | · | -87.0% | -65.9% | 7 |
| TLPHTALPHERA, INC. | $28,000 | -$14.3 M | · | -114.2% | · | 15 |
| SKVISKINVISIBLE, INC. | $20,000 | -$1.1 M | · | · | -33.4% | 16 |
| BDPTBIOADAPTIVES, INC. | $18,278 | -$1.6 M | · | · | +2.3% | 7 |
| PRFXPRF Technologies Ltd. | $17,000 | -$5.0 M | · | -96.9% | · | 3 |
| GNLXGENELUX Corp | $8,000 | -$32.1 M | · | -170.0% | · | 4 |
| TCRTAlaunos Therapeutics, Inc. | $5,000 | -$4.2 M | · | -198.1% | · | 11 |
| OWPCOne World Products, Inc. | $4,863 | -$3.9 M | · | · | · | 5 |
| ADTXAditxt, Inc. | $3,195 | -$43.1 M | · | -1183.4% | · | 5 |
| AMLXAmylyx Pharmaceuticals, Inc. | $0 | -$144.7 M | · | -61.6% | · | 5 |
| ANVSAnnovis Bio, Inc. | $0 | -$28.9 M | · | -220.6% | · | 6 |
| APLMApollomics Inc. | $0 | -$53.9 M | · | -233.7% | · | 5 |
| BYSIBeyondSpring Inc. | $0 | -$1.0 M | · | · | · | 12 |
| CAPRCAPRICOR THERAPEUTICS, INC. | $0 | -$105.0 M | · | -46.6% | · | 15 |
| DSGNDesign Therapeutics, Inc. | $0 | -$69.8 M | · | -30.7% | · | 3 |
| FULCFulcrum Therapeutics, Inc. | $0 | -$74.9 M | · | -25.3% | · | 6 |
| HSTCHST Global, Inc. | $0 | -$146,210 | · | · | · | 7 |
| HURATuHURA Biosciences, Inc. | $0 | -$30.1 M | · | -169.2% | · | 5 |
| IXHLIncannex Healthcare Inc. | $0 | -$19.3 M | · | -47.8% | · | 3 |
| KALAKALA BIO, Inc. | $0 | -$27.0 M | · | -279.2% | · | 10 |
| KPRXKIORA PHARMACEUTICALS INC | $0 | -$10.8 M | · | -51.7% | · | 10 |
| MBRXMoleculin Biotech, Inc. | $0 | -$33.6 M | · | -256.0% | · | 10 |
| MNPRMonopar Therapeutics | $0 | -$13.7 M | · | -14.2% | · | 6 |
| NGNENeurogene Inc. | $0 | -$90.4 M | · | -31.4% | · | 4 |
| NKTXNkarta, Inc. | $0 | -$104.1 M | · | -28.9% | · | 3 |
| NNVCNANOVIRICIDES, INC. | $0 | -$8.2 M | · | -101.5% | · | 4 |
| PLRXPLIANT THERAPEUTICS, INC. | $0 | -$149.3 M | · | -61.5% | · | 7 |
| PTIXProtagenic Therapeutics, Inc.\new | $0 | $1.4 M | · | · | · | 9 |
| RCKTROCKET PHARMACEUTICALS, INC. | $0 | -$223.1 M | · | -60.3% | · | 10 |
| RNTXRein Therapeutics, Inc. | $0 | -$49.9 M | · | -139.9% | · | 11 |
| SPRBSPRUCE BIOSCIENCES, INC. | $0 | -$39.0 M | · | -109.2% | · | 4 |
| SYBXSYNLOGIC, INC. | $0 | -$1.0 M | · | -8.2% | · | 10 |
| TENXTENAX THERAPEUTICS, INC. | $0 | -$52.6 M | · | -55.6% | · | 8 |
| VTVTvTv Therapeutics Inc. | $0 | -$27.0 M | · | -70.4% | · | 13 |
| XCUREXICURE, INC. | $0 | -$4.9 M | · | -92.5% | · | 10 |
| ZNTLZentalis Pharmaceuticals, Inc. | $0 | -$137.1 M | · | -49.5% | · | 4 |
| AAPGASCENTAGE PHARMA GROUP INTERNATIONAL | CNY 980.6 M | -CNY 405.4 M | -41.4% | -249.8% | · | 3 |
| INCRIntercure Ltd. | ILS 238.8 M | -ILS 67.8 M | -30.5% | -15.9% | +93.0% | 6 |
| ZYBTZhengye Biotechnology Holding Ltd | CNY 116.4 M | -CNY 69.8 M | -71.3% | -26.1% | · | 4 |
| HYFTMindWalk Holdings Corp. | CAD 24.5 M | -CAD 30.2 M | -123.3% | -102.0% | +11.8% | 6 |
| MCUJFMEDICURE INC | CAD 21.9 M | -CAD 1.0 M | -4.7% | -5.1% | +1.7% | 10 |
| XTXXFAdastra Holdings Ltd. | CAD 13.3 M | -CAD 4.3 M | -32.2% | -21.1% | · | 3 |
| IMRNImmuron Ltd | AUD 7.3 M | -AUD 5.2 M | -71.6% | -50.2% | +23.7% | 10 |
| MMTZFMindMaze Therapeutics Holding SA | CHF 6.3 M | -CHF 98.2 M | · | -99.4% | · | 3 |
| AVCRFAvricore Health Inc. | CAD 4.7 M | -CAD 668,977 | -14.4% | -33.6% | · | 9 |
| ADXNAddex Therapeutics Ltd. | CHF 404,102 | CHF 7.1 M | · | 130.4% | -31.9% | 7 |
| GELSGelteq Ltd | AUD 165,645 | -$6.6 M | · | -43.0% | · | 2 |
| KZIAKAZIA THERAPEUTICS LTD | AUD 42,000 | -AUD 20.7 M | · | · | · | 8 |
| IFRXInflaRx N.V. | EUR 29,331 | -EUR 45.6 M | · | · | · | 3 |
| ALXOALX ONCOLOGY HOLDINGS INC | · | -$101.7 M | · | -145.7% | · | 5 |
| ANIXAnixa Biosciences Inc | · | -$10.9 M | · | -62.2% | · | 13 |
| APVOAptevo Therapeutics Inc. | · | -$26.0 M | · | -234.6% | · | 8 |
| ATHEALTERITY THERAPEUTICS LTD | · | -AUD 12.1 M | · | · | · | 3 |
| ATOSATOSSA THERAPEUTICS, INC. | · | -$34.8 M | · | -62.7% | · | 5 |
| BDRXBiodexa Pharmaceuticals Plc | · | -GBP 6.4 M | · | -64.7% | · | 9 |
| BETRFBetterLife Pharma Inc. | · | -CAD 9.1 M | · | · | · | 0 |
| BIVIBIOVIE INC. | · | -$22.1 M | · | -150.8% | · | 0 |
| BIXTBIOXYTRAN, INC | · | -$2.1 M | · | · | · | 8 |
| BNTCBenitec Biopharma Inc. | · | -$45.5 M | · | -33.2% | · | 6 |
| BPTHBIO-PATH HOLDINGS, INC. | · | -$9.9 M | · | -3325.7% | · | 8 |
| CATXPerspective Therapeutics, Inc. | · | -$103.1 M | · | -41.4% | · | 14 |
| CMNDClearmind Medicine Inc. | · | -$3.9 M | · | -179.4% | · | 0 |
| COCPCocrystal Pharma, Inc. | · | -$8.8 M | · | -111.4% | · | 3 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | · | -$78.5 M | · | -54.2% | · | 8 |
| CTXRCitius Pharmaceuticals, Inc. | · | -$39.7 M | · | -57.8% | · | 10 |
| CYDYCytoDyn Inc. | · | -$42.7 M | · | · | · | 3 |
| CYTOFAltamira Therapeutics Ltd. | · | -$8.5 M | · | · | · | 3 |
| DCOYDecoy Therapeutics Inc. | · | -$12.5 M | · | -338.3% | · | 8 |
| DMRADamora Therapeutics, Inc. | · | -$209.8 M | · | -163.8% | · | 0 |
| EDSAEdesa Biotech, Inc. | · | -$7.2 M | · | -99.6% | · | 9 |
| ELDNEledon Pharmaceuticals, Inc. | · | -$45.6 M | · | -63.6% | · | 5 |
| ELVNEnliven Therapeutics, Inc. | · | -$103.7 M | · | -27.0% | · | 0 |
| ENVBEnveric Biosciences, Inc. | · | -$8.8 M | · | -304.0% | · | 5 |
| EOCNGalmed Pharmaceuticals Ltd. | · | -$10.3 M | · | -64.2% | · | 7 |
| EQEquillium, Inc. | · | -$22.4 M | · | -94.0% | · | 3 |
| ERNAErnexa Therapeutics Inc. | · | -$14.1 M | · | -686.7% | · | 14 |
| FBRXForte Biosciences, Inc. | · | -$69.4 M | · | -122.3% | · | 4 |
| FLNAFILANA THERAPEUTICS, INC. | · | -$91.0 M | · | -82.7% | · | 5 |
| GNPXGenprex, Inc. | · | -$16.2 M | · | -338.7% | · | 8 |
| GTBPGT Biopharma, Inc. | · | -$28.4 M | · | · | · | 10 |
| HEPAHepion Pharmaceuticals, Inc. | · | -$8.3 M | · | · | · | 4 |
| IMNNImunon, Inc. | · | -$14.5 M | · | -256.4% | · | 6 |
| IMRXImmuneering Corp | · | -$56.0 M | · | -43.1% | · | 4 |
| INMInMed Pharmaceuticals Inc. | · | -$12.6 M | · | -173.1% | · | 5 |
| INTIInhibitor Therapeutics, Inc. | · | -$3.3 M | · | · | · | 9 |
| LITSLite Strategy, Inc. | · | -$71.2 M | · | -243.0% | · | 9 |
| LRMRLarimar Therapeutics, Inc. | · | -$165.7 M | · | -132.6% | · | 8 |
| MBIOMUSTANG BIO, INC. | · | -$1.9 M | · | · | · | 3 |
| MTNBMatinas BioPharma Holdings, Inc. | · | -$10.3 M | · | -166.6% | · | 10 |
| NBPNovaBridge Biosciences | · | -$46.3 M | · | -21.4% | · | 7 |
| NERVMinerva Neurosciences, Inc. | · | -$293.4 M | · | · | · | 8 |
| NIKANIKA PHARMACEUTICALS, INC | · | -$76,398 | · | · | · | 4 |
| NMADNOMAD POWER SOLUTIONS, INC. | · | -$6.1 M | · | -115.9% | · | 5 |
| OGENORAGENICS INC | · | -$9.8 M | · | · | · | 12 |
| OMEROMEROS CORP | · | -$3.4 M | · | · | · | 12 |
| ORKAOruka Therapeutics, Inc. | · | -$105.4 M | · | -22.3% | · | 10 |
| OTLCOncotelic Therapeutics, Inc. | · | $249.3 M | · | 184.0% | · | 4 |
| PHIOPhio Pharmaceuticals Corp. | · | -$8.7 M | · | -69.9% | · | 8 |
| PKTXProtoKinetix, Inc. | · | -$393,650 | · | -123.0% | · | 5 |
| PPBTPURPLE BIOTECH LTD. | · | -$26.4 M | · | -124.0% | · | 4 |
| PULMPulmatrix, Inc. | · | -$5.2 M | · | -80.9% | · | 12 |
| PVLAPALVELLA THERAPEUTICS, INC. | · | -$41.7 M | · | -92.1% | · | 11 |
| QNRXQuoin Pharmaceuticals Ltd. | · | -$15.8 M | · | -141.6% | · | 3 |
| QNTMQuantum Biopharma Ltd. | · | · | · | · | · | 1 |
| SLSSELLAS Life Sciences Group, Inc. | · | -$26.9 M | · | -66.9% | · | 7 |
| SNGXSOLIGENIX, INC. | · | -$11.1 M | · | -235.5% | · | 15 |
| SVRASavara Inc | · | -$118.8 M | · | -63.5% | · | 9 |
| TLSATiziana Life Sciences Ltd | · | -$11.9 M | · | -250.5% | · | 0 |
| TPSTTempest Therapeutics, Inc. | · | -$26.3 M | · | -203.6% | · | 5 |
| TRFATRAFALGAR INTERNATIONAL, INC. | · | -$331,612 | · | · | · | 5 |
| TVRDTvardi Therapeutics, Inc. | · | -$18.2 M | · | · | · | 13 |
| VERUVERU INC. | · | -$22.7 M | · | -89.7% | · | 16 |
| XBITXBiotech Inc. | · | -$45.5 M | · | -28.2% | · | 6 |
| XRTXXORTX Therapeutics Inc. | · | -CAD 1.7 M | · | -18.4% | · | 0 |
| VREOFVireo Growth Inc. | $268.8 M | -$68.1 M | -25.3% | -37.5% | +40.4% | 6 |
| SEPNSepterna, Inc. | $46.0 M | -$48.9 M | -106.4% | -12.2% | · | 3 |
| BFRIBiofrontera Inc. | $41.7 M | -$10.5 M | -25.3% | -141.3% | +17.2% | 6 |
| BHSTBIOHARVEST SCIENCES INC. | $34.5 M | -$11.1 M | -32.3% | -83.2% | · | 3 |
| TRDAEntrada Therapeutics, Inc. | $25.4 M | -$143.8 M | -565.5% | -39.1% | · | 3 |
| ZBIOZenas BioPharma, Inc. | $10.0 M | -$377.7 M | · | -136.2% | · | 3 |
| COYACoya Therapeutics, Inc. | $7.9 M | -$21.2 M | -267.1% | -51.4% | · | 4 |
| BOLTBolt Biotherapeutics, Inc. | $7.7 M | -$33.4 M | -433.7% | -79.7% | +101.6% | 6 |
| CAMPCamp4 Therapeutics Corp | $3.5 M | -$80.4 M | · | -145.1% | · | 3 |
| UPBUpstream Bio, Inc. | $2.9 M | -$143.4 M | · | -35.4% | · | 3 |
| LGVNLongeveron Inc. | $1.2 M | -$22.7 M | · | -164.7% | -26.6% | 6 |
| BSPKBespoke Extracts, Inc. | $1.1 M | -$1.0 M | · | · | · | 6 |
| SXTP60 DEGREES PHARMACEUTICALS, INC. | $1.0 M | -$7.4 M | -732.8% | -196.4% | · | 4 |
| ONCOOnconetix, Inc. | $815,371 | -$14.0 M | · | -115.5% | · | 3 |
| ELABPMGC Holdings Inc. | $590,084 | -$7.7 M | -1313.0% | -106.9% | · | 3 |
| LIPOLIPELLA PHARMACEUTICALS INC. | $536,357 | -$5.0 M | -935.2% | -198.1% | · | 4 |
| HINDVyome Holdings, Inc | $319,714 | -$10.3 M | · | · | -51.0% | 12 |
| BFRGBullFrog AI Holdings, Inc. | $116,670 | -$6.5 M | · | -183.0% | · | 3 |
| CNTBConnect Biopharma Holdings Ltd | $64,000 | -$55.5 M | · | -82.7% | · | 3 |
| HCWBHCW Biologics Inc. | $54,232 | -$8.0 M | · | · | · | 6 |
| KAYSKaya Holdings, Inc. | $7,134 | -$2.1 M | · | · | -62.9% | 11 |
| AZTRAzitra, Inc. | $0 | -$11.0 M | · | -230.7% | · | 4 |
| BRNSBarinthus Biotherapeutics plc. | $0 | -$66.4 M | · | -65.0% | · | 6 |
| CNBXCNBX Pharmaceuticals Inc. | $0 | -$313,976 | · | · | · | 11 |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | $0 | -$38.6 M | · | -66.8% | · | 3 |
| OGIORGANIGRAM GLOBAL INC. | CAD 159.8 M | -CAD 45.4 M | -28.4% | -14.9% | · | 6 |
| PYRGFPyroGenesis Canada Inc. | CAD 19.0 M | -CAD 32.2 M | -169.2% | -111.6% | · | 4 |
| CTORCITIUS ONCOLOGY, INC. | · | -$24.8 M | · | -54.4% | · | 0 |
| ELTXElicio Therapeutics, Inc. | · | -$39.6 M | · | · | · | 3 |
| GANXGain Therapeutics, Inc. | · | -$20.2 M | · | -155.7% | · | 4 |
| KTTAPasithea Therapeutics Corp. | · | -$20.4 M | · | -58.4% | · | 2 |
| MAIAMAIA Biotechnology, Inc. | · | -$22.4 M | · | -745.2% | · | 3 |
| NXTSNexentis Technologies Inc. | · | -$4.0 M | · | -38.6% | · | 7 |
| PCSAProcessa Pharmaceuticals, Inc. | · | -$13.6 M | · | -373.0% | · | 7 |
| PTPIPetros Pharmaceuticals, Inc. | · | $1.9 M | · | · | · | 5 |
| VBIOValion Bio, Inc. | · | -$8.9 M | · | -91.8% | · | 4 |
"·" marks a figure not available in our data.